Germline BRCA-mutated metastatic pancreatic adenocarcinoma

Germline BRCA-mutated metastatic pancreatic adenocarcinoma is an advanced stage IV malignancy arising from the exocrine ductal epithelial cells of the pancreas that has disseminated to distant anatomical sites

Germline BRCA-mutated metastatic pancreatic adenocarcinoma is an advanced stage IV malignancy arising from the exocrine ductal epithelial cells of the pancreas that has disseminated to distant anatomical sites

This specific clinical subset occurs in individuals who carry inherited, deleterious or suspected deleterious germline alterations in either the *BRCA1* or *BRCA2* tumor suppressor genes Pathophysiologically, loss of functional BRCA proteins impairs homologous recombination repair of DNA double-strand breaks, inducing genomic instability and rendering the tumor selectively vulnerable to DNA-damaging cytotoxic agents and PARP inhibition

This specific clinical subset occurs in individuals who carry inherited, deleterious or suspected deleterious germline alterations in either the *BRCA1* or *BRCA2* tumor suppressor genes

Pathophysiologically, loss of functional BRCA proteins impairs homologous recombination repair of DNA double-strand breaks, inducing genomic instability and rendering the tumor selectively vulnerable to DNA-damaging cytotoxic agents and PARP inhibition Clinically, it represents an aggressive, highly lethal presentation of pancreatic cancer, typically managed systemically due to widespread metastatic involvement

Clinically, it represents an aggressive, highly lethal presentation of pancreatic cancer, typically managed systemically due to widespread metastatic involvement